IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Debt-to-Equity: N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:IOLCP IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
61 GF Score
Price ₹165.58
GF Value ₹101.92
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is IOL Chemicals And Pharmaceuticals Debt-to-Equity?

IOL Chemicals And Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹0 Mil. IOL Chemicals And Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹0 Mil. IOL Chemicals And Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for IOL Chemicals And Pharmaceuticals's Debt-to-Equity or its related term are showing as below:

NSE:IOLCP' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.07   Max: 2.37
Current: 0.08

During the past 13 years, the highest Debt-to-Equity Ratio of IOL Chemicals And Pharmaceuticals was 2.37. The lowest was 0.00. And the median was 0.07.

NSE:IOLCP's Debt-to-Equity is ranked better than
75.74% of 812 companies
in the Drug Manufacturers industry
Industry Median: 0.275 vs NSE:IOLCP: 0.08

IOL Chemicals And Pharmaceuticals  (NSE:IOLCP) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

IOL Chemicals And Pharmaceuticals Debt-to-Equity Related Terms

IOL Chemicals And Pharmaceuticals Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for IOL Chemicals And Pharmaceuticals's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IOL Chemicals And Pharmaceuticals Debt-to-Equity Chart

IOL Chemicals And Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.05 0.02 0.07 0.08

IOL Chemicals And Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.09 N/A 0.08 N/A

NSE:IOLCP vs ZTS: Debt-to-Equity Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IOL Chemicals And Pharmaceuticals Debt-to-Equity vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Debt-to-Equity falls into.


NSE:IOLCP
61GF Score
IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IOL Chemicals And Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

IOL Chemicals And Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1330.2 + 24) / 17985.5
=0.08

IOL Chemicals And Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Jun. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?

Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued. The current stock price of ₹165.58 is trading 62.5% above its estimated GF Value™ of ₹101.92. GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:IOLCP:

  • Debt-to-Equity: N/A
  • GF Value™: ₹101.92 vs. price of ₹165.58 (62.5% above fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IOL Chemicals And Pharmaceuticals Business Description

Other Exchanges 524164:India
Address 85, Industrial Area, A, Ludhiana, PB, IND, 141 003
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
61GF Score

Get the complete analysis for NSE:IOLCP

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹165.58
Price
₹101.92
GF Value